CHD5 and cancer: Pei et al. reported that SLC16A1-AS1 is downregulated in hepatocellular carcinoma and inhibits multiple-cell behaviors, such as migration and invasion by regulating the miR-301b-3p/CHD5 axis so as to suppress cancer progression and increase cancer cell sensitivity to radiosensitivity [19][21].